Thiene, Italy

Lanfranco Callergaro

This inventor holds 1 USPTO granted patent. Top assignee: Fidia Advanced Biopolymers S.r.l.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lanfranco Callergaro. Retrieved from https://idiyas.com/inventor/lanfranco-callergaro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lanfranco Callergaro: Innovator in Biocompatible Compositions

Introduction

Lanfranco Callergaro is a notable inventor based in Thiene, Italy. He has made significant contributions to the field of biocompatible and biodegradable compositions, particularly in the area of injectable hyaluronic acid derivatives. His innovative work has the potential to impact various medical applications.

Latest Patents

Lanfranco Callergaro holds a patent for an injectable hyaluronic acid derivative that combines pharmaceuticals and cells. This composition is disclosed as being biocompatible and biodegradable, comprising at least one hyaluronic acid benzyl ester or auto-cross-linked derivative. It also includes at least one mammalian cell and/or pharmacologically or biologically active substances, as well as micro-particles such as fibers, granules, microspheres, or sponge fragments of a hyaluronic acid derivative.

Career Highlights

Callergaro is associated with Fidia Advanced Biopolymers S.r.l., where he continues to develop innovative solutions in biopolymers. His work focuses on enhancing the efficacy and safety of injectable compositions for medical use.

Collaborations

Some of his notable coworkers include Marco Radice and Andrea Pastorello, who contribute to the collaborative efforts in advancing biopolymer technologies.

Conclusion

Lanfranco Callergaro's contributions to the field of biocompatible compositions highlight his role as an innovator in the medical technology sector. His patent for an injectable hyaluronic acid derivative showcases the potential for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…